Signaling pathways
-
BA2699 MC-Val-Cit-PAB-RetapamulinSummary: Part of an antibody-coupled active molecule consisting of the protein synthesis inhibitor Retapamulin linked to MC-Val-Cit-PAB. -
BA2700 MC-Val-Cit-PAB-rifabutinSummary: MC-Val-Cit-PAB-rifabutin is part of an antibody-coupled active molecule. -
BA2701 NHS-MMAFSummary: NHS-MMAF is a modified MMAF. -
BA2702 PSMA-Val-Cit-PAB-MMAESummary: PSMA-Val-Cit-PAB-MMAE is a novel small molecule PSMA-targeting conjugate based on MMAE. -
BA2703 DL-01Summary: DL-01 is an ADC active molecule-linker coupling. -
BA2704 SC-VC-PAB-DM1Summary: SC-VC-PAB-DM1 is part of an antibody-coupled reactive molecule with anticancer activity. -
BA2705 Azido-PEG4-Val-Cit-PAB-MMAESummary: Azido-PEG4-Val-Cit-PAB-MMAE is part of an antibody coupled active molecule (drug-linkerconjugateforADC). -
BA2706 MC-Val-Cit-PAB-clindamycinSummary: MC-Val-Cit-PAB-clindamycin is part of an antibody-coupled active molecule. -
BA2709 Amino-PEG4-GGFG-DxdSummary: Can be used for ADC synthesis. -
BA2710 MC-Val-Cit-PAB-IndibulinSummary: MC-Val-Cit-PAB-Indibulin is part of an antibody-coupled active molecule.

